Physician

James Patrick Hoye, MD

According to 2025 Medicare claims, James Hoye, MD (NPI: 1730145426) practices family practice in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Bristol, MA. This provider's primary affiliated billing organization is DOCTORS JAMES AND KELLY HOYE PARTNERS IN FAMILY CARE (NPI: 1053379123; TIN: 043174401) and primary practice location at 02764-1824. Hoye is affiliated with the CareMax Accountable Care Network, LLC (ACO ID: A5080), participating under the MSSP model.

Hoye's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 728 traditional Medicare patients, billed 7,592 HCPCS/CPT codes, and received $423,433 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 22,880 prescription claims across 831 beneficiaries totaling $1,604,960 in drug costs, led by Eliquis (Apixaban). DME data shows 594 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $277,927 to $423,433. Similarly, Part D prescription costs have risen steadily, from $898,086 to $1,604,960. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $36,772 to $88,800.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	765	5,914	$277,927
2016	745	6,243	$307,967
2017	737	5,690	$264,943
2018	723	5,614	$266,154
2019	813	5,868	$272,457
2020	799	5,214	$247,057
2021	764	5,067	$282,617
2022	735	5,064	$295,204
2023	805	6,580	$407,241
2024	728	7,592	$423,433

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	553	13,871	$898,086
2016	655	15,840	$1,062,864
2017	716	15,792	$1,081,447
2018	692	15,178	$1,065,368
2019	813	14,844	$1,069,583
2020	831	14,620	$1,053,109
2021	787	12,997	$988,853
2022	761	12,299	$1,139,359
2023	861	15,605	$1,402,557
2024	831	22,880	$1,604,960

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	199	765	$31,310
2016	125	748	$40,179
2017	88	594	$30,524
2018	68	486	$20,661
2019	79	464	$19,832
2020	53	510	$28,814
2021	85	468	$29,730
2022	43	528	$33,505
2023	41	395	$31,510
2024	31	594	$112,685

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	506	506	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	537	1,306	$91
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	388	757	$12
G0444	Annual depression screening, 5 to 15 minutes	452	453	$10
36415	Insertion of needle into vein for collection of blood sample	492	930	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	548	16,708	$323,062
Rybelsus	Semaglutide	70	3,840	$116,947
Xarelto	Rivaroxaban	129	5,829	$106,767
Januvia	Sitagliptin Phosphate	122	4,664	$85,430
Trulicity	Dulaglutide	43	2,214	$73,005

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	14	$39,477
A6010	Collagen based wound filler, dry form, sterile, per gram of collagen	N	N/R	11	$12,988
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	12	$12,065
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	28	$9,859
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	N/R	28	$7,871

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for James Patrick Hoye, MD?

Tedicare shows public-source Medicare data for James Patrick Hoye, MD (NPI 1730145426), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Patrick Hoye, MD have ACO affiliation data?

James Patrick Hoye, MD is shown with ACO affiliation data for CareMax Accountable Care Network, LLC (MSSP, ACO ID A5080).

What billing organization is linked to James Patrick Hoye, MD?

James Patrick Hoye, MD is linked to DOCTORS JAMES AND KELLY HOYE PARTNERS IN FAMILY CARE (billing NPI 1053379123) in the available physician profile data.

Does James Patrick Hoye, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.